SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-041516
Filing Date
2010-02-26
Accepted
2010-02-26 06:04:52
Documents
11
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1539526
2 STOCK PURCHASE AGREEMENT dex1037.htm EX-10.37 484861
3 SUBSIDIARIES OF BIOMARIN PHARMACEUTICAL INC. dex211.htm EX-21.1 2422
4 CONSENT OF KPMG LLP dex231.htm EX-23.1 2864
5 CONSENT OF PRICEWATERHOUSECOOPERS, LLP dex232.htm EX-23.2 1873
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 8644
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 8709
8 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4003
9 BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS dex991.htm EX-99.1 115671
10 GRAPHIC g62862g08a24.jpg GRAPHIC 39208
11 GRAPHIC g62862g08b24.jpg GRAPHIC 8726
  Complete submission text file 0001193125-10-041516.txt   2236294
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 10636012
SIC: 2834 Pharmaceutical Preparations